Overall, our findings support the hypothesis that HDL-C may reduce APOE4-related AD risk via mechanisms involving lipid metabolism, amyloid clearance, vascular protection, and neurotrophic and anti-inflammatory support. Here, APOE is linked to Alzheimer disease.